Caffeine in the Prevention of Post-operative Nausea and Vomiting

• Status: Completed
• Trial end date: 2005-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this study is to determine if caffeine 500 mg intravenously is efficacious when added to standard anti-emetic prophylaxis in the prevention of post-operative nausea and vomiting (PONV) in patients undergoing ambulatory surgery under general anesthesia.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beth Israel Deaconess Medical Center
• Treatments: Caffeine

Criteria

Inclusion Criteria:

• Patient having ambulatory surgery

• Patient receiving general anesthesia

Exclusion Criteria:

• Patient is not willing to sign informed consent

• Patient does not speak or understand sufficient English